Listed

Angiodynamics Inc: Form 10-Q for the period ended Feb 28, 2014

Filed with the SEC on Apr 9, 2014 and accepted by EDGAR at Apr 9, 2014, 16:23 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-02-28. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-12-06 to 2014-02-28$88.2mus-gaap:SalesRevenueNet
Revenue9 months2013-06-01 to 2014-02-28$260.4mus-gaap:SalesRevenueNet
Cost of revenue3 months2013-12-06 to 2014-02-28$42.6mus-gaap:CostOfGoodsSold
Cost of revenue9 months2013-06-01 to 2014-02-28$127.3mus-gaap:CostOfGoodsSold
Gross profit3 months2013-12-06 to 2014-02-28$45.6mus-gaap:GrossProfit
Gross profit9 months2013-06-01 to 2014-02-28$133.0mus-gaap:GrossProfit
Research and development3 months2013-12-06 to 2014-02-28$7.0mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2013-06-01 to 2014-02-28$20.8mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2013-12-06 to 2014-02-28$7.6mus-gaap:OperatingIncomeLoss
Operating income9 months2013-06-01 to 2014-02-28$10.4mus-gaap:OperatingIncomeLoss
Interest expense3 months2013-12-06 to 2014-02-28$917.0kus-gaap:InterestExpense
Interest expense9 months2013-06-01 to 2014-02-28$3.1mus-gaap:InterestExpense
Income tax3 months2013-12-06 to 2014-02-28$476.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2013-06-01 to 2014-02-28$268.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2013-12-06 to 2014-02-28$5.1mus-gaap:NetIncomeLoss
Net income9 months2013-06-01 to 2014-02-28$4.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2013-12-06 to 2014-02-28$0.14us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2013-06-01 to 2014-02-28$0.13us-gaap:EarningsPerShareDiluted
Basic EPS3 months2013-12-06 to 2014-02-28$0.15us-gaap:EarningsPerShareBasic
Basic EPS9 months2013-06-01 to 2014-02-28$0.13us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2013-12-06 to 2014-02-2835,704,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2013-06-01 to 2014-02-2835,372,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Capital expenditure9 months2013-06-01 to 2014-02-28$9.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2014-02-28$7.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-02-28$140.1mus-gaap:AssetsCurrent
Total assetsAt period end2014-02-28$792.2mus-gaap:Assets
Current liabilitiesAt period end2014-02-28$63.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-02-28$254.5mus-gaap:Liabilities
Current portion of debtAt period end2014-02-28$5.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2014-02-28$537.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-14-137100. Last ingested by Listed: Nov 4, 2026, 20:24 ET. Listed shows no prices and gives no investment advice.